EcoDrugPlus

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSCGOG00000007758
Gene Symbol: LOC115021451
3 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSCGOG00000016371
Gene Symbol: LOC115015567
3 Cross references
181 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSCGOG00000013487
Gene Symbol: GNRHR
3 Cross references
191 Possible Orthologues:

Granzyme-Like Protein 1

Ensembl ID : ENSCGOG00000011931
Gene Symbol: LOC115007259
2 Cross references
1073 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSCGOG00000000990
Gene Symbol: GHRHR
3 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1-Like

Ensembl ID : ENSCGOG00000021947
Gene Symbol: LOC115027907
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCGOG00000018041
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCGOG00000018410
Gene Symbol: GUCY1A2
3 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCGOG00000018052
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSCGOG00000018301
Gene Symbol: HSP90AB1
3 Cross references
355 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1

Ensembl ID : ENSCGOG00000022466
Gene Symbol: LOC115029002
3 Cross references
317 Possible Orthologues:

Hepatoma-Derived Growth Factor-Related Protein 2-Like

Ensembl ID : ENSCGOG00000001545
Gene Symbol: LOC115012729
2 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).